Atlas Trials

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Clinical trial NCT07105098 · RECRUITING

Trial details

NCT number
NCT07105098
Sponsor
Neurocrine Biosciences
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2025-08-11
Primary completion
2027-11-01
Enrollment
284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.